P. Duarte, “First experience on the effectiveness and safety of lenalidomide- bortezomib-dexamethasone (RVd) as induction treatment in patients with recent diagnosis of multiple myeloma (MM) who are candidates for hematopoietic transplant in Argentina. Collaborative study of the Argentine Group of Multiple Myeloma (GAMM)”, RH, vol. 26, no. 2, pp. 36–45, Sep. 2022.